While it seems to be common knowledge that drinking while pregnant is unwise, many children are harmed by the effects of fetal alcohol spectrum disorder, reported CNN. Older studies suggest…
According to an article from Medical Xpress, a recent study suggests that an anti-cancer drug commonly used to treat leukemia may be effective in treating a rare form of ovarian…
Clearside Biomedical recently developed a new treatment for impaired vision. The drug, tested in a group with uveitis, succeeded not only in treating symptoms of disease, but also resulted in…
According to a story from Charcot-Marie-Tooth Disease News, the U.S. Food and Drug Administration (FDA), under the leadership of commissioner Scott Gottlieb, has begun to change clinical trials by accepting…
The only conference in the United States that shows guidance as how to involve patients through the process of clinical research. Industry Fees: $1,595 Early Bird - available until 2/09/18 $1,695…
According to a story from Medical Xpress, the addition of crizotinib with radiation therapy could help reduce hearing loss associated with the treatment in patients with neurofibromatosis II. Crizotinib is…
The BIOIMAGING 2018 Conference in Portugal recently announced it’s “Best Student Paper” award. The award went to a Nigerian doctoral student who identified a new technique for examining the retina.…
A new study by Northwestern scientists shares that patients with Huntington's disease are much less likely to develop cancer because the disease is toxic to cancer cells, recently reported by News…
The Southern Daily Echo originally reported that a majority of pancreatic cancer patients don't receive life-extending treatment after diagnosis. Recently, the Pancreatic Cancer UK charity reported that only a small…
A Boston biotech company called FNDA has collaborated with research organizations to utilize artificial intelligence, AI, to aid drug development and disease diagnosis, reports FierceBiotech. They are currently looking for…
In 2016 the Centers for Disease Control verified that Zika virus caused birth defects such as microcephaly. This shocked the world. We witnessed the first mosquito-borne disease known to result…
CRISPR gene editing technology is still mostly in its infancy, but the new tool is already causing a lot of excitement, particularly in the treatment of genetically-linked diseases. A recent…
According to a story from PressReleasePoint, a new partnership has developed to generate artificial intelligence technology that will help diagnose people with a variety of rare diseases. The partnership consists…
Dr. Woodrin Wright studies telomeres – the part of our DNA that determines aging. It's also involved in some cancers. It seems like a cruel irony then that Dr. Wright…
According to a story from Science Daily, researchers at the University of Michigan have discovered why it is possible for basal cell carcinomas, a common form of skin cancer, to…
New medicines for Parkinson’s may be around the corner. The United States Food and Drug Administration (US FDA) recently approved one drug, and accepted application another. Both new drugs treat…
According to an article from kait8.com, the pharmaceutical company Yisheng Biopharma announced that YS-ON-001, a leading candidate for the company, received Orphan Drug Designation from the U.S. Food and Drug…
According to an article from brightsurf.com, a commonly used allergy medication called cetirizine (commonly marketed under the name Zyrtec) was able to prevent relapse in patients with neuromyelitis optica in…
Mesoblast Limited announced the primary endpoint success of a phase three trial on February 21st. The drug tested aims to help treat steroid refractory acute graft versus host disease. No…
According to an article from Newswise, the Coriell Institute for Medical Research announced the release of rare new N-glycanase deficiency samples. These samples will be available to researchers so that…
According to story from Alpha Galileo, a recent study demonstrated that neuroblastoma cells, a form of cancer that forms in nerve tissue and often occurs in childhood, can transition into…
A new cannabis treatment is going into trial in Australia to treat patients with Tourette syndrome, reports The Courier Mail. This will be the first study in Australia to use…
According to a story from PRNewswire, a recent study has revealed several new, less invasive biomarkers for multiple sclerosis. A biomarker is a statistical indicator that can be used to…
Biopharmaceutical company CorMEdix Inc. announced on Friday, February 23rd that its product taurolidine received orphan drug status from the United States Food and Drug Administration (US FDA). Taurolidine exists currently…
Recent findings point to two bacteria that work together to create colon cancer. Researchers recognized the bacteria as the same ones that occur in cases of familial adenomatous polyposis. These…
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
